Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients.

Transplantation - 15 May 2011

Zarkhin Valeriya, Lovelace Patricia A, Li Li, Hsieh Szu-Chuan, Sarwal Minnie M

Abstract excerpt

BACKGROUND: Recently published pediatric trial of Rituximab for the treatment of CD20+ acute renal allograft rejection (AR) demonstrated transient depletion of circulating/intragraft B cells (Zarkhin et al., Am J Transplant 2008; 8: 2607). In this study, we have evaluated phenotypic definition of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Murine-Derived
Share to B-Cell Activating Factor
Share to B-Lymphocyte Subsets

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Memory

Share to Lymphocyte Depletion

Share to Rituximab

Share to Steroids

Share to Viremia

Source

Identifiers

PMID: 21403590
DOI: 10.1097/TP.0b013e318213df29

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21403590-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients.PMID 21403590Read ↗

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.Semantic proximity Read ↗

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.Semantic proximity Read ↗

Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Semantic proximity Read ↗

Regulatory B cells: the cutting edge of immune tolerance in kidney transplantationSemantic proximity Read ↗

Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology.Semantic proximity Read ↗

Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation.Semantic proximity Read ↗

Treatment of Chronic Active Antibody-mediated Rejection in Renal Transplant Recipients – A single center retrospective studySemantic proximity Read ↗

Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney TransplantSemantic proximity Read ↗

Memory B cells in transplantation.Semantic proximity Read ↗

Viral infections and immune reconstitution interaction after pediatric allogenic hematopoietic stem cell transplantationSemantic proximity Read ↗

Successful eculizumab treatment as an adjunctive therapy to desensitization in ABO-incompatible living donor kidney transplantation and its molecular phenotypes.Semantic proximity Read ↗

Donor HLA-DQ reactive B cells clonally expand under chronic immunosuppression and include atypical CD21 <sup>low</sup> CD27 <sup>−</sup> B cells with high-avidity germline B-cell receptorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.